Analyst consensus rating
PROCEPT BioRobotics Analyst Rating: Hold
PRCT is rated Hold by 11 analysts with a $21.64 target. As of 2026-08-18.
Direct answer
PROCEPT BioRobotics's consensus rating is Hold.
11 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $21.64.
Forecast evidence checked August 18, 2026.
Get free PROCEPT BioRobotics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $21.70
- Average price target
- $21.64
- High price target
- $28.00
- Low price target
- $16.00
- Low target gap
- -26.3%
- Target upside
- -0.3%
- High target gap
- +29.1%
- Target range width
- 55.3%
- Consensus rating
- Hold
- Analysts
- 11
- Evidence date
- August 18, 2026
- Valid through
- August 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for PROCEPT BioRobotics?
PROCEPT BioRobotics has a verified Hold consensus. The same dataset has an average price target of $21.64.
How far are PROCEPT BioRobotics's low and high targets from the recorded price?
The low target implies -26.3%, while the high target implies +29.1%.
How many analysts are included in PROCEPT BioRobotics's consensus?
The verified consensus includes 11 analysts.
How is PROCEPT BioRobotics's target upside or downside calculated?
The average target of $21.64 is divided by the recorded price of $21.70, then one is subtracted to produce -0.3%. This does not guarantee a future return.
When was PROCEPT BioRobotics's analyst forecast verified?
The data was verified on 2026-08-18. The dataset is valid through 2026-08-25.